Objective and subjective results of the Bonebridge transcutaneous active direct-drive bone conduction hearing implant

Farid Alzhrani


Objectives: To investigate the effectiveness of a bone-anchored hearing implant system (Bonebridge implant technology) as a rehabilitation treatment for individuals with conductive or mixed hearing losses.


Methods: This is a retrospective cohort study. Twelve implanted ears with conductive or mixed hearing losses were implanted with this device at a tertiary university hospital between 2012 and 2016. Audiological tests included pure tone air conduction (AC) and bone conduction (BC) measurements and unaided and aided sound-field thresholds. To evaluate the speech intelligibility in a quiet environment, the speech discrimination score (SDS) was tested using Arabic monosyllabic words, and the speech reception threshold (SRT) was measured using Arabic disyllabic words spoken in front of them. The subjective sound quality was assessed with the Hearing Implant Sound Quality Index (HISQUI).


Results: In comparison with the unaided condition, there was a significant improvement in the aided thresholds, SDS, and SRT. Comparing the aided and unaided thresholds, the average AC threshold improved with an average functional gain of 40±6.3dB. The unaided SRT improved from 72.5 dB hearing levels (HL)(median) to 27.5 dB HL (median) when aided, and patients performed 71% better, on average, based on the SDS with the help of the device. The HISQUI questionnaire revealed high satisfaction with the device sound quality.


Conclusion: Patients with conductive and mixed hearing loss substantially benefit from the Bonebridge active transcutaneous BC hearing implant.


Bonebridge; Transcutaneous; Bone-anchored; Hearing Aids; Audiological outcome

Full Text:



Cremers CW, O’Connor AF, Helms J, Roberson J, Clarós P, Frenzel H, et al. International consensus on Vibrant Soundbridge® implantation in children and adolescents. Int J Pediatr Otorhinolaryngol 2010; 74: 1267-1279.

Schmerber S, Deguine O, Marx M, Van de Heyning P, Sterkers O, Mosnier I, et al. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use. Eur Arch Otorhinolaryngol 2017; 274: 1835-1851.

Vyskocil E, Liepins R, Kaider A, Blineder M, Hamzavi S. Sound localization in patients with congenital unilateral conductive hearing loss with a transcutaneous bone conduction implant. Otol Neurotol 2017; 38: 318-324.

Hobson JC, Roper AJ, Andrew R, Rothera MP, Hill P, Green KM. Complications of bone-anchored hearing aid implantation. J Laryngol Otol 2010; 124: 132-136.

Hassepass F, Bulla S, Aschendorff A, Maier W, Traser L, Steinmetz C, et al. TheBonebridgeas a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents. Eur Arch Otorhinolaryngol 2015; 272: 2235-2241.

Mulla O, Agada F, Reilly PG. Introducing the Sophono Alpha 1 abutment free bone conduction hearing system. Clin Otolaryngol 2012; 37: 168-169.

Rahne T, Seiwerth I, Götze G, Heider C, Radetzki F, Herzog M, et al. Functional results after Bonebridge implantation in adults and children with conductive and mixed hearing loss. Eur Arch Otorhinolaryngol 2015; 272: 3263-3269.

Manrique M, Sanhueza I, Manrique R, de Abajo J. A new bone conduction implant: surgical technique and results. Otol Neurotol 2014; 35: 216-220.

Sprinzl G, Lenarz T, Ernst A, Hagen R, Wolf-Magele A, Mojallal H, et al. First European multicenter results with a new transcutaneous bone conduction hearing implant system: shorttermsafety and efficacy. Otol Neurotol 2013; 34: 1076-1083.

Baumgartner WD, Hamzavi JS, Böheim K, Wolf-Magele A, Schlögel M, Riechelmann H, et al. A new transcutaneous bone conduction hearing implant: short-term safety and efficacy in children. Otol Neurotol 2016; 37: 713-720.

Ihler F, Volbers L, Blum J, Matthias C, Canis M. Preliminaryfunctional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss. Otol Neurotol 2014; 35: 211-215.

Barbara M, Perotti M, Gioia B, Volpini L, Monini S. Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss. Acta Otolaryngol 2013; 133: 1058-1064.

Pfiffner F, Caversaccio M, Kompis M. Audiological results with Baha in conductive and mixed hearing loss. Adv Otorhinolaryngol 2011; 71: 73-83.

Bianchin G, Bonali M, Russo M, Tribi L. Active bone conduction system: outcomes with the Bonebridge transcutaneous device. ORL J Otorhinolaryngol Relat Spec 2015; 77: 17-26.

Badran K, Bunstone D, Arya AK, Suryanarayanan R, Mackinnon N. Patient satisfaction with the bone-anchored hearing aid: a 14-year experience. Otol Neurotol 2006; 27: 659-666.

Laske RD, Röösli C, Pfiffner F, Veraguth D, Huber AM. Functional results and subjective benefit of a transcutaneous bone conduction device in patients with single-sided deafness. Otol Neurotol 2015; 36: 1151-1156.

Hougaard DD, Boldsen SK, Jensen AM, Hansen S, Thomassen PC. A multicenter study on objective and subjective benefits with a transcutaneous bone-anchored hearing aid device: first Nordic results. Eur Arch Otorhinolaryngol 2017; 274: 3011-3019.


  • There are currently no refbacks.

Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.